» Articles » PMID: 2446442

Reactivity with Monoclonal Antibodies of Viruses from an Episode of Foot-and-mouth Disease

Overview
Journal Virus Res
Specialty Microbiology
Date 1987 Sep 1
PMID 2446442
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

A panel of 12 monoclonal antibodies (MAbs) raised against foot-and-mouth disease virus (FMDV) of serotype C1 (FMDV C-S8c1) and 11 MAbs raised against other FMDVs have been used to evaluate the reactivity of 14 isolates of FMDV of serotype C1 (series FMDV C-S), 12 of them from one disease episode (Spain 1979-1982). The assays used were immunoelectrotransfer blot, immunodot and neutralization of infectivity. None of the isolates could be clearly distinguished by its reactivity with 6 non-neutralizing and 2 neutralizing MAbs raised against FMDV C-S8c1. In contrast, the isolates were distinguished in two groups by a 10(2)-fold difference in their reactivity with 6 neutralizing MAbs. The reactivity of MAbs with synthetic peptides indicated that conserved and non-conserved epitopes recognised respectively by neutralizing MAbs 4G3 and SD6 are localized in the immunogenic region (amino acids 138-156) of VP1. Thus, epidemiologically related FMDVs differ in at least one epitope critical for virus neutralization.

Citing Articles

Structures of Foot-and-Mouth Disease Virus with Bovine Neutralizing Antibodies Reveal the Determinant of Intraserotype Cross-Neutralization.

He Y, Li K, Wang L, Sun Z, Cao Y, Li P J Virol. 2021; 95(24):e0130821.

PMID: 34586859 PMC: 8610593. DOI: 10.1128/JVI.01308-21.


An Adenovirus Vector Expressing FMDV RNA Polymerase Combined with a Chimeric VLP Harboring a Neutralizing Epitope as a Prime Boost Strategy to Induce FMDV-Specific Humoral and Cellular Responses.

Rangel G, Martin V, Barcena J, Blanco E, Alejo A Pharmaceuticals (Basel). 2021; 14(7).

PMID: 34358101 PMC: 8308840. DOI: 10.3390/ph14070675.


Structures of Foot-and-mouth Disease Virus with neutralizing antibodies derived from recovered natural host reveal a mechanism for cross-serotype neutralization.

He Y, Li K, Cao Y, Sun Z, Li P, Bao H PLoS Pathog. 2021; 17(4):e1009507.

PMID: 33909694 PMC: 8081260. DOI: 10.1371/journal.ppat.1009507.


Generation and characterisation of recombinant FMDV antibodies: Applications for advancing diagnostic and laboratory assays.

Shimmon G, Kotecha A, Ren J, Asfor A, Newman J, Berryman S PLoS One. 2018; 13(8):e0201853.

PMID: 30114227 PMC: 6095514. DOI: 10.1371/journal.pone.0201853.


Human Memory B Cells Producing Potent Cross-Neutralizing Antibodies against Human Parechovirus: Implications for Prevalence, Treatment, and Diagnosis.

Westerhuis B, Benschop K, Koen G, Claassen Y, Wagner K, Bakker A J Virol. 2015; 89(15):7457-64.

PMID: 25948742 PMC: 4505642. DOI: 10.1128/JVI.01079-15.